tiprankstipranks
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
Holding SCNI?
Track your performance easily

Scinai Immunotherapeutics (SCNI) Ownership - Who Owns Scinai Immunotherapeutics?

305 Followers

Scinai Immunotherapeutics (SCNI) Ownership Overview

7.40%0.02%<0.01%<0.01%92.58%
7.40%
Insiders
<0.01% Other Institutional Investors
<0.01% ETFs
92.58% Public Companies and
Individual Investors
The ownership structure of Scinai Immunotherapeutics (SCNI) stock is a mix of institutional, retail, and individual investors. Approximately 0.02% of the company’s stock is owned by Institutional Investors, 7.40% is owned by Insiders, and 92.58% is owned by Public Companies and Individual Investors.
The ownership structure of Scinai Immunotherapeutics (SCNI) stock is a mix of institutional, retail, and individual investors. Approximately 0.02% of the company’s stock is owned by Institutional Investors, 7.40% is owned by Insiders, and <0.01% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
62,400Insider7.40%214,656
137Institution0.02%471
2Institution<0.01%7

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
137Institution0.02%471

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2Institution<0.01%7

FAQ

Who Owns Scinai Immunotherapeutics (SCNI)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 7.40% is held by insiders, and 92.58% is held by retail investors.
    What percentage of Scinai Immunotherapeutics (SCNI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Scinai Immunotherapeutics (SCNI) stock is held by institutional investors.
      What percentage of Scinai Immunotherapeutics (SCNI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 92.58% of Scinai Immunotherapeutics (SCNI) stock is held by retail investors.
        Who owns the most shares of Scinai Immunotherapeutics (SCNI)?
        STONE DANIEL E. owns the most shares of Scinai Immunotherapeutics (SCNI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis